HF
DRUG

HRT Financial’s Bright Minds Biosciences DRUG Stock Holding History

HRT Financial’s Portfolio DRUG Stock Details DRUG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-13,568
Closed -$489K – 2823
2025
Q1 		$489K Buy
+13,568
New +$497K ﹤0.01% 1471
2024
Q1 		– Sell
-16,845
Closed -$24K – 2486
2023
Q4 		$24K Buy
16,845
+3,475
+26% +$4.96K ﹤0.01% 2023
2023
Q3 		$21K Buy
+13,370
New +$35.6K ﹤0.01% 2066

Other funds holding DRUG

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

HRT Financial's DRUG Position: Q2 2025 in Review

HRT Financial sold out of Bright Minds Biosciences (DRUG) in Q2 2025, closing a stake of 13,568 shares — an estimated $489K sold.

HRT Financial first reported a position in DRUG in Q3 2023 and held it in 3 quarters. The position peaked at $489K in Q1 2025. 47 funds tracked by Wall St. Rank hold DRUG as of Q2 2025.

  • HRT Financial reported no remaining Bright Minds Biosciences position as of Q2 2025 after selling out during the quarter.
  • HRT Financial sold 13,568 Bright Minds Biosciences shares in Q2 2025, an estimated $489K.
  • HRT Financial first reported a position in Bright Minds Biosciences in Q3 2023 and held it in 3 quarters.
  • HRT Financial's Bright Minds Biosciences position peaked at $489K in Q1 2025.
  • 47 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q2 2025.

Based on HRT Financial's 13F filing for Q2 2025, filed 14 Aug 2025.